4 results
The objective of this study is to obtain clinical performance (outcomes) data andsurvivorship for commercially available Zimmer Persona knee implants implanted inprimary total knee arthroplasty.
Assess the safety and performance of the HeartMate PHP in supporting patients who are hemodynamically unstable, or at risk of being hemodynamically unstable, while undergoing percutaneous coronary interventions (PCI).
Part A - CX-2009 Monotherapy: Every 21-Day Dosing RegimenThe primary objective of Part A is to determine the safety profile of CX-2009, the maximum tolerated dose (MTD)/recommended Phase 2 dose (RP2D), and the dose-limiting toxicities(DLTs) of CX-…
The objective of this study is to obtain clinical performance (outcomes) data and survivorship for commercially available Zimmer Persona knee implants implanted in primary total knee arthroplasty.